Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone-Reference-Cited by-同舟云学术

Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone

Published:2023-08 Issue: Volume:188 Page:104059
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Crocetto Felice^ORCID,Ferro Matteo,Buonerba Carlo,Bardi Luca,Dolce Pasquale,Scafuri Luca,Mirto Benito Fabio,Verde Antonio,Sciarra Antonella,Barone Biagio,Calogero Armando,Sagnelli Caterina,Busetto Gian Maria,Del Giudice Francesco,Cilio Simone,Sonpavde Guru,Di Trolio Rossella,Della Ratta Giuseppe Luca,Barbato Gabriele,Di Lorenzo Giuseppe

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference31 articles.

1. Cardiotoxicity of immune checkpoint inhibitors: a systematic review and meta-analysis of randomised clinical trials;Agostinetto;Eur. J. Cancer,2021

2. Efficacy and safety of first-line systemic therapy for metastatic renal cell carcinoma: a systematic review and network meta-analysis;Bosma;Eur. Urol. Open Sci.,2022

3. Outcomes associated with first-line anti-PD-1/ PD-L1 agents vs. sunitinib in patients with sarcomatoid renal cell carcinoma: a systematic review and meta-analysis;Buonerba;Cancers,2020

4. Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma;Cheng;J. Hepatol.,2022

5. The lack of statistical power of subgroup analyses in meta-analyses: a cautionary note;Cuijpers;Epidemiol. Psychiatr. Sci.,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Cellular Stress and Cutaneous Manifestations in Renal Cell Carcinomas—A Narrative Review;Journal of Clinical Medicine;2024-06-21

2. Cardiovascular Toxicity Associated With Androgen Receptor Axis-Targeted Agents in Patients With Prostate Cancer: A Meta-analysis of Randomized Controlled Trials;Clinical Genitourinary Cancer;2024-06

3. Vascular Endothelial Growth Factor (VEGF) and Its Role in the Cardiovascular System;Biomedicines;2024-05-10

4. Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study;Cancer Medicine;2024-05

5. Second-line treatment options in metastatic castration-resistant prostate cancer after progression on first-line androgen-receptor targeting therapies: A systematic review and Bayesian network analysis;Critical Reviews in Oncology/Hematology;2024-04